Chargement en cours...
Efficacy and safety of vortioxetine (Lu AA21004), 15 and 20 mg/day: a randomized, double-blind, placebo-controlled, duloxetine-referenced study in the acute treatment of adult patients with major depressive disorder
This study assessed the efficacy, tolerability and safety of vortioxetine versus placebo in adults with recurrent major depressive disorder. This double-blind, randomized, placebo-controlled study included 608 patients [Montgomery–Åsberg Depression Rating Scale (MADRS) total score≥26 and Clinical Gl...
Enregistré dans:
| Auteurs principaux: | , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Lippincott Williams And Wilkins
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3979887/ https://ncbi.nlm.nih.gov/pubmed/24257717 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/YIC.0000000000000018 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|